News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
696,710 Results
Type
Article (39619)
Company Profile (200)
Press Release (656891)
Section
Business (209079)
Career Advice (1916)
Deals (34977)
Drug Delivery (96)
Drug Development (79181)
Employer Resources (148)
FDA (15795)
Job Trends (15253)
News (346959)
Policy (32738)
Tag
Academia (2715)
Alliances (45895)
Alzheimer's disease (1285)
Approvals (15714)
Artificial intelligence (140)
Bankruptcy (321)
Best Places to Work (12219)
Biotechnology (146)
Breast cancer (129)
Cancer (1165)
Cardiovascular disease (108)
Career advice (1546)
Cell therapy (261)
Clinical research (62933)
Collaboration (416)
Compensation (206)
COVID-19 (2338)
C-suite (106)
Data (1155)
Diabetes (161)
Diagnostics (6571)
Earnings (93849)
Employer resources (121)
Events (121127)
Executive appointments (325)
FDA (16356)
Funding (371)
Gene therapy (193)
GLP-1 (639)
Government (4740)
Healthcare (20451)
Infectious disease (2432)
Inflammatory bowel disease (120)
Interviews (322)
IPO (16852)
Job creations (3407)
Job search strategy (1371)
Layoffs (452)
Legal (7632)
Lung cancer (185)
Manufacturing (194)
Medical device (14168)
Medtech (14173)
Mergers & acquisitions (18252)
Metabolic disorders (444)
Neuroscience (1581)
NextGen Class of 2024 (7070)
Non-profit (5001)
Northern California (1521)
Obesity (259)
Opinion (195)
Patents (110)
People (55542)
Phase I (19604)
Phase II (27899)
Phase III (20949)
Pipeline (469)
Postmarket research (2182)
Preclinical (8251)
Radiopharmaceuticals (256)
Rare diseases (237)
Real estate (5707)
Regulatory (21713)
Research institute (2429)
Resumes & cover letters (338)
Southern California (1339)
Startups (3312)
United States (14004)
Vaccines (549)
Weight loss (201)
Date
Today (104)
Last 7 days (753)
Last 30 days (3981)
Last 365 days (37751)
2024 (34621)
2023 (42380)
2022 (53016)
2021 (57344)
2020 (56700)
2019 (50587)
2018 (37411)
2017 (33678)
2016 (33120)
2015 (38525)
2014 (31629)
2013 (26798)
2012 (28035)
2011 (28758)
2010 (25653)
Location
Africa (725)
Arizona (155)
Asia (41413)
Australia (6779)
California (3383)
Canada (1308)
China (264)
Colorado (154)
Connecticut (162)
Europe (92435)
Florida (472)
Georgia (124)
Illinois (366)
Indiana (207)
Kansas (94)
Maryland (616)
Massachusetts (2731)
Michigan (174)
Minnesota (289)
New Jersey (984)
New York (981)
North Carolina (793)
Northern California (1521)
Ohio (147)
Pennsylvania (854)
South America (1121)
Southern California (1339)
Texas (477)
Utah (95)
Washington State (375)
696,710 Results for "20 20 bioresponse".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Multiple sclerosis
Study Casts Doubt on Benefit of Anti-CD20 Therapies in Multiple Sclerosis
New research has found that MS patients treated with anti-CD20 antibodies, such as Roche’s Ocrevus, do not experience significantly slower progression of disability.
September 26, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Personalis to Participate at Upcoming Investor Conferences - November 20, 2024
November 20, 2024
·
1 min read
Press Releases
CIRM Marks 20 Years of Advancing Regenerative Medicine in California
November 15, 2024
·
3 min read
Press Releases
Advisory Committee on Immunization Practices Recommends PREVNAR 20® (20-Valent Pneumococcal Conjugate Vaccine) for Adults Aged 50 and Older
October 24, 2024
·
11 min read
Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024
Longeveron Inc. today announced that it will participate in the Virtual Life Sciences Investor Forum taking place June 20, 2024.
June 17, 2024
·
1 min read
Pharm Country
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
Inventiva announced the availability of the preparatory documents for the Combined General Meeting of June 20, 2024.
May 30, 2024
·
9 min read
Press Releases
AbbVie Awards 20 Individuals Living With Migraine To Support Career Aspirations
November 15, 2024
·
9 min read
Lone Star Bio
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent, Inc. announced that it closed an additional $4 million from Norwest Venture Partners to round out its Series A financing at $20 million with Good Growth Capital and IAG Capital Partners co-leading the deal.
June 27, 2024
·
4 min read
BioForest
RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
RareCyte, Inc. announced today the completion of a $20M financing from new and existing investors.
June 27, 2024
·
2 min read
Press Releases
Press Release: Sequana Medical announces Extraordinary General Meeting of Shareholders on 20 December 2024
November 20, 2024
·
4 min read
1 of 69,671
Next
